Indeterminate Pulmonary Nodules: Clinical Evaluation of LungLB

What is the Purpose of this Study?

This study focuses on individuals who have a suspicious lung nodule that is or will be scheduled for a lung biopsy. The purpose of the study is to compare the performance of a test called LungLB to standard-of-care biopsies to find lung cancer. LungLB is an investigational test that detects circulating tumor cells in order to correlate the results of the LungLB test with biopsy results. It is not intended as a screening, confirmatory or stand-alone diagnostic test. The study will access medical records to collect information about participant demographics, socioeconomics, social history, disease status, and relevant clinical and pathology information.


Eligibility

  • At least 18 years old with a CT identified indeterminate pulmonary nodule and scheduled for biopsy, at the time of consent.
  • Planned biopsy nodule of interest:
Show more

Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

Clinical evaluation of LungLB in subjects presenting with indeterminate pulmonary nodules.

Study Details
Disease Type/Condition

Other

Principal Investigator

Lee, Christopher

Co-Investigators

George Chaux, Sara Ghandehari

Age Group

Adult

Phase

N/A

IRB Number

STUDY00002138

ClinicalTrials.gov ID

NCT05171491

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Details
Disease Type/Condition

Other

Principal Investigator

Lee, Christopher

Age Group

Adult

Phase

N/A

IRB Number

LAI-001

ClinicalTrials.gov ID

NCT05171491

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org